Related Experiment Videos
Angelman syndrome: correlations between epilepsy phenotypes and genotypes
B A Minassian1, T M DeLorey, R W Olsen
1Department of Neurology, University of California, Los Angeles, School of Medicine, and West Los Angeles DVA Medical Center, 90073, USA.
Annals of Neurology
|April 18, 1998
Summary
Angelman syndrome (AS) patients with chromosome 15q11-13 deletions experience severe epilepsy. Other AS genotypes, like UBE3A mutations, are linked to milder, drug-responsive epilepsy.
Area of Science:
- Genetics
- Neurology
- Epileptology
Background:
- Angelman syndrome (AS) is a genetic disorder associated with developmental delays and neurological abnormalities.
- Epilepsy is a common comorbidity in AS, but the relationship between specific genotypes and epilepsy phenotypes requires further elucidation.
Purpose of the Study:
- To compare epilepsy phenotypes across different Angelman syndrome genotypes.
- To investigate the correlation between specific genetic causes of AS and the severity and characteristics of epilepsy.
Main Methods:
- Prospective selection of twenty AS patients based on molecular and cytogenetic diagnosis.
- Long-term (6-72 hours) continuous video-electroencephalography (EEG) monitoring.
- Classification of AS genotypes into four classes: chromosome 15q11-13 deletions (Class I), uniparental disomy (Class II), methylation imprinting abnormalities (Class III), and UBE3A gene mutations (Class IV).
Main Results:
- All AS patients exhibited characteristic EEG patterns with diffuse, bifrontally dominant slow waves.
- Class I patients (15q11-13 deletions) presented with severe, intractable epilepsy, including atypical absences and myoclonias.
- Classes II, III, and IV patients showed either no epilepsy or mild, drug-responsive epilepsy with less frequent seizure types.
Conclusions:
- Maternally inherited chromosome 15q11-13 deletions are strongly associated with severe, intractable epilepsy in Angelman syndrome.
- Loss-of-function UBE3A mutations, uniparental disomy, and methylation imprinting abnormalities in AS are linked to milder epilepsy phenotypes.
- The involvement of additional genes within the 15q11-13 deletion region, such as GABRB3, may contribute to the severe epilepsy observed in some AS patients.